# GORE VIABAHN Endoprosthesis With Heparin Bioactive Surface in the Treatment of SFA Obstructive Disease (VIPER)

> **NCT00541307** · NA · COMPLETED · sponsor: **W.L.Gore & Associates** · enrollment: 119 (actual)

## Conditions studied

- Peripheral Vascular Diseases

## Interventions

- **DEVICE:** Treatment with the GORE VIABAHN Endoprosthesis with Heparin Bioactive Surface

## Key facts

- **NCT ID:** NCT00541307
- **Lead sponsor:** W.L.Gore & Associates
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-10
- **Primary completion:** 2011-06
- **Final completion:** 2011-06
- **Target enrollment:** 119 (ACTUAL)
- **Last updated:** 2012-12-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00541307

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00541307, "GORE VIABAHN Endoprosthesis With Heparin Bioactive Surface in the Treatment of SFA Obstructive Disease (VIPER)". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT00541307. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*